Menu
EMMAY
The leading alternative protein (mycelium) food tech company in Vietnam
2 Million
target amount (USD)
4
Max investors
8 mil
Pre-money
500 k
Min ticket
equity
Offering type
★
Investment summary
★
2 million
Products sold
400
Points of sales
$1.5 million
Accummulated revenue
- The trend: Alternative protein especially alternative meat is inevitable. Key players in animal meat industries also made moves in the game
- Market size: Market size of alternative meat is huge (<2% of animal meat)
- Team & insights: The team are top researchers & experts in the field. Emmay team is approaching cutting-edge knowledge of the mycelium technology
- Upside potential: Being early investor in a first big name in alternative meat startup
- Risk diversification: Innovative food tech and traditional processing products
- Impacts: Social impacts, values and community
★★
Pitch
★★
Problem
Our food system is in the state of emergency
The list of things wrong with the way we produce food is practically never-ending; in short, we eat highly processed food low in nutritional value that makes us sick and obese. Excessive use of fertilizers and pesticides, deforestation, and depleted soils are fueling global warming. As the global temperature rises, increasingly extreme weather is destroying our crops and making our farms infertile.
- Food insecurity
- Animal protein inefficiency
- Diseases & health concerns
- Social, enviromental & economic challenges
Solution
A mission-driven food company using mycelium to create nutritious food
Aside from providing a safe and healthy source of protein for vegans and vegetarians, meat alternatives help to reduce the potential environmental impact of meat in a variety of ways.
Delicious, protein-packed, products made from the most sustainable source on Earth: mycelium.
Mycelium or fungus meat is a unique meat alternative that utilizes fungal growths to produce a meat-like substance. Among millions of fungi strains in the world, Emmay R&D team has successfully created and isolated a new type. This new type is used to create its own Mycelium fibers, Mycoprotein substrates and Cellulose membranes for meat & seafood substitute.
Product
Healthy for you, healthy for the Earth too
Emmay is committed to creating products with superior nutrition. To do that, Emmay uses clean-label and locally-sourced ingredients packed with vitamins, minerals, omega, proteins and fiber.
Creative mushroom-based products
Emmay creates the most nutritious mushroom-based products on the market today.
Alternative meats (fungi-based)
Traction
Named one of gaming changers in foodtech industry
We are in talks with top suppliers in F&B and FMCG to bring our products to the hypermarkets and CVS.
Our products have already been sold in Aeon Mall, Go! Market, E-mart, Coop Mart and on Tiki store.
Customers
Our customers are trying their best to eat a little better everyday
Business model
Selling our products online, direct-to-retail and through distributors to stores nationwide & overseas
Market
Huge room for growth
Competition
Fungi-based meats have more advantageous features than other types
Compared to other types, fundi-based meats are savoury, cost-effective, healthy, and scalable in terms of production volume.
Vision and strategy
A brand that consumers can trust when it comes to sustainability and nutrition
Vision
To make better non-meat foods by using the revolutionary fungi-based technology
Mission
To make the global food system truly sustainable by reducing the need to make food from animals
Team
Top-notch researchers & leading scientists in mycelium technology
★★★
Risks & Finance
★★★
Risks
Risks you may face when investing in Emmay
Emmay is still in an early phase. There can be no assurance that we will ever operate profitably. The likelihood of our success should be considered in light of the problems, expenses, difficulties, complications and delays usually encountered by early-stage companies. Emmay may not be successful in attaining the objectives necessary for it to overcome these risks and uncertainties.
Finance
Registration required
This part contains sensitive information about the company. Only authorized investors can view the content.